Progenesis Launches the 1st COVID-19 Testing for IVF

Date: 2020-03-27

Progenesis Launches the 1st COVID-19 Testing for IVF

Progenesis is excited to introduce COVID-IVF, the first COVID-19 test for in-vitro-fertilization (IVF). Our new testing services for COVID-19 are now available to IVF patients and clinic personnel. Contact our Director of Sales Meryem Bousfiha at [email protected] directly for more information.

Learn more about what COVID-IVF can offer you here:

Progenesis is Open and Operational During COVID-19 Outbreak

Date: 2020-03-20

Dear valued Progenesis partners,

We have been receiving an overwhelming amount of questions and concerns regarding our operating hours and other laboratory-related logistics for the past few days. On behalf of the Progenesis team, I wanted to send out this message to address these concerns.

Progenesis is closely monitoring all information, orders, and recommendations posted by the Food and Drug Administration (FDA), Centers for Disease Control (CDC), World Health Organization (WHO) and other national and local government officials and authorities about this unsettling pandemic.

Progenesis Lab currently remains open and operational and we are still able to receive samples for testing. We continue to fulfill what makes us one of the leaders in the industry with our fastest turnaround time (5-7 business days) and excellent customer service (fast response). We would like to ensure you that Progenesis is consistently following the guidelines to maintain our operations. Currently, we have implemented the social distancing strategy at our office and allowed some employees to work from home during the outbreak.

We appreciate your time and patience with us. During this particular time period, please contact (858) 257-2122 or email [email protected] for a fast response to your question. For immediate contact, please send your questions to [email protected]


Nabil Arrach, Ph.D.

CEO and Scientific Director, Progenesis

Happy St. Patrick’s Day from Progenesis Team

🍀Happy #StPatricksDay from Progenesis Team and our adorable company mascot, Ted 🐶! Though some celebrations might have been canceled due to the outbreak of #COVID19, we still would like to wish you a safe, lucky, and healthy holiday.

#ProgenesisTeam #StPattysDay


COVID-19 Company Update

Date: 2020-03-17


Dear valued Progenesis partners,

On behalf of Progenesis and our entire team, I would like to share our proactive precautions regarding COVID-19 with you. Amid ongoing concern about COVID-19, Progenesis’ top priority is the health, safety, and well-being of our customers and employees. Our heart goes out to anyone affected by this outbreak.

At Progenesis, serving you is the most important thing we do. We take pride in complying with all regulatory standards and will continue to follow all guidelines set forth by healthcare authorities. We fully understand there may be concerns regarding the shipment of samples due to the latest travel bans. At this moment, we do not anticipate any changes within our operation as a result of these restrictions and will continue accepting samples unless instructed otherwise.

Our employees are dedicated to assisting you to our best ability. In the event where Progenesis has to stop the laboratory operation due to government instructions, travel ban or any unforeseen events, our laboratory is equipped with storage capabilities to hold your samples until testing can be resumed.

As we monitor and evaluate the developments related to COVID-19, please rest assured that if anything changes, our customers will be notified immediately of all necessary actions. If you have any questions, please call our customer support service line (858) 257-2122 or visit our website for more information:



Nabil Arrach, Ph.D.

CEO and Scientific Director, Progenesis

International Women's Day 2020

International Women’s Day at Progenesis

Did you know that more than half of Progenesis employees are women? On this #InternationalWomensDay, we are acknowledging our own female team. They work across all departments at our company, from laboratory to customer support, billing to marketing. Today we celebrate some of these women at #Progenesis making impacts in the #ivf field. We are incredibly proud and honored to have them on board.

#InternationalWomensDay #IWD2020 #EachforEqual #ProgenesisTeam

Progenesis is now in Mexico.

Progenesis is Now in Mexico

By Progenesis Team

March 02, 2020

Progenesis is excited to announce that Progenesis is expanding internationally to Mexico! We are proud to share this milestone as we continue to thrive as one of the fastest-growing genetic testing companies in the world. It has been our long term goal to spread our latest technology and service on an international scale, and now we are planning to combine our innovation and passion towards helping families deliver healthy babies in Mexico.

At Progenesis, we strive to meet and exceed our patients’ needs by providing them the most advanced technology in the market and the most accurate testing results. We believe that our expertise can benefit those who struggle with infertility to start a healthy family. We take pride in our innovative work provided by our passionate and intelligent team and look forward to this new chapter for Progenesis in 2020.

Progenesis in Coral Springs, Florida.

Join Progenesis in Coral Springs, Florida!

Progenesis in Coral Springs, Florida.

Join us for an educational social gathering in Coral Springs, Florida on February 18th. Hearing from our CEO, Dr. Nabil Arrach and his unique take on the current status of PGT-A testing and its future directions during this event. Don’t miss out on this great opportunity!

Hosted by Progenesis and Family Source Consultants.

Join Progenesis at the Next CARA Meeting in Chicago!

If you’re in the Chicago area on June 20th, join Progenesis at the CARA Meeting for dinner and an exciting discussion with our CEO & Scientific Director, Dr. Nabil Arrach, on “Mosaicism Detection: Error Rate and Clinical Implication.”


Space is limited. Please RSVP here!

Fertility and Sterility Journal Club On-Demand: Cell-Free DNA for Aneuploidy Screening in Embryos

Last week, Progenesis CEO, Dr. Nabil Arrach, joined other experts in assisted reproductive technology to discuss the recent Fertility and Sterility publication, Pushing the limits of detection: investigation of cell-free DNA for aneuploidy screening in embryos.” The discussion took place via the Fertility and Sterility online Journal Club and was streamed live to viewers on Thursday, November 15th.

If you weren’t able to tune in for the live event, you can still catch the intriguing discussion on this exciting topic through an “On Demand” option. Simply follow THIS LINK. You will be prompted to enter your email address and then redirected to the taped version of the Journal Club. Enjoy!

Cell-free DNA for aneuploidy screening in embryos? Join the discussion

Progenesis is dedicated to innovation in reproductive health. As such, our expert scientists are constantly working to improve our products and practices through research and development.

We recently collaborated on a study investigating the use of cell-free DNA for aneuploidy screening in embryos. The manuscript detailing this study, “Pushing the limits of detection: investigation of cell-free DNA for aneuploidy screening in embryos,” was published in the August 2018 edition of Fertility and Sterility, the official journal of the American Society of Reproductive Medicine.

This week we learned that our study has been selected for Fertility and Sterility’s upcoming Journal Club Global. The event will be live-streamed on Thursday November 15th at 10AM PST (1PM EST).

REGISTER for the online event to join in the discussion of this exciting topic!